T2	Participants 689 844	The single and combination groups comprised 14 and 13 patients, respectively, and there was no significant difference between the background of both groups
T1	Participants 271 504	prevention of nausea, vomiting and appetite loss induced by remission induction chemotherapy for acute myeloid leukemia was compared by randomization between granisetron alone and combination with granisetron plus methylprednisolone.
